Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.

Glassberg J, Minnitti C, Cromwell C, Cytryn L, Kraus T, Skloot GS, Connor JT, Rahman AH, Meurer WJ.

Am J Hematol. 2017 Jul;92(7):622-631. doi: 10.1002/ajh.24742. Epub 2017 Jun 5.

PMID:
28370266
2.

Sickle cell disease: wheeze or asthma?

Cohen RT, Klings ES, Strunk RC.

Asthma Res Pract. 2015 Dec 8;1:14. doi: 10.1186/s40733-015-0014-2. eCollection 2015. Review.

3.

The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.

DeBaun MR, Strunk RC.

Lancet. 2016 Jun 18;387(10037):2545-53. doi: 10.1016/S0140-6736(16)00145-8. Review.

4.

The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.

Andemariam B, Adami AJ, Singh A, McNamara JT, Secor ER, Guernsey LA, Thrall RS.

Transl Res. 2015 Sep;166(3):254-68. doi: 10.1016/j.trsl.2015.03.001. Epub 2015 Mar 16.

5.

Cough and wheeze events are temporally associated with increased pain in individuals with sickle cell disease without asthma.

Diep RT, Busani S, Simon J, Punzalan A, Skloot GS, Glassberg JA.

Br J Haematol. 2015 Sep;170(5):732-4. doi: 10.1111/bjh.13325. Epub 2015 Mar 5. No abstract available.

6.

Wheezing is common in children with sickle cell disease when compared with controls.

Galadanci NA, Liang WH, Galadanci AA, Aliyu MH, Jibir BW, Karaye IM, Inusa BP, Vermund SH, Strunk RC, DeBaun MR.

J Pediatr Hematol Oncol. 2015 Jan;37(1):16-19. doi: 10.1097/MPH.0000000000000239.

7.

Asthma management in sickle cell disease.

Gomez E, Morris CR.

Biomed Res Int. 2013;2013:604140. doi: 10.1155/2013/604140. Epub 2013 Nov 10. Review.

8.

Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice.

Zhang H, Xu H, Weihrauch D, Jones DW, Jing X, Shi Y, Gourlay D, Oldham KT, Hillery CA, Pritchard KA Jr.

J Lipid Res. 2013 Nov;54(11):3009-15. doi: 10.1194/jlr.M038281. Epub 2013 Aug 16.

9.

Sickle-cell disease in Malawian children is associated with restrictive spirometry: a cross-sectional survey.

Cook J, Jefferis O, Matchere P, Mbale E, Rylance J.

Int J Tuberc Lung Dis. 2013 Sep;17(9):1235-8. doi: 10.5588/ijtld.12.0965. Epub 2013 Jul 3.

10.

Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination.

Szczepanek SM, Secor ER Jr, Bracken SJ, Guernsey L, Rafti E, Matson A, Thrall RS, Andemariam B.

Pediatr Res. 2013 Aug;74(2):141-7. doi: 10.1038/pr.2013.85. Epub 2013 May 31.

11.

Wheezing and asthma are independent risk factors for increased sickle cell disease morbidity.

Glassberg JA, Chow A, Wisnivesky J, Hoffman R, Debaun MR, Richardson LD.

Br J Haematol. 2012 Nov;159(4):472-9. doi: 10.1111/bjh.12049. Epub 2012 Sep 12.

12.

Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice.

Pritchard KA Jr, Feroah TR, Nandedkar SD, Holzhauer SL, Hutchins W, Schulte ML, Strunk RC, Debaun MR, Hillery CA.

Am J Respir Cell Mol Biol. 2012 Mar;46(3):389-96. doi: 10.1165/rcmb.2011-0097OC. Epub 2011 Oct 27.

13.

Asthma is a distinct comorbid condition in children with sickle cell anemia with elevated total and allergen-specific IgE levels.

Ross JG, Bernaudin F, Strunk RC, Kamdem A, Arnaud C, Hervé M, Delacourt C, DeBaun MR.

J Pediatr Hematol Oncol. 2011 Jul;33(5):e205-8. doi: 10.1097/MPH.0b013e31820db7b1.

14.

Asthma in sickle cell disease: implications for treatment.

Blake K, Lima J.

Anemia. 2011;2011:740235. doi: 10.1155/2011/740235. Epub 2011 Mar 3.

15.

D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma.

Nandedkar SD, Weihrauch D, Xu H, Shi Y, Feroah T, Hutchins W, Rickaby DA, Duzgunes N, Hillery CA, Konduri KS, Pritchard KA Jr.

J Lipid Res. 2011 Mar;52(3):499-508. doi: 10.1194/jlr.M012724. Epub 2010 Dec 3.

16.

Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung.

Wang W, Xu H, Shi Y, Nandedkar S, Zhang H, Gao H, Feroah T, Weihrauch D, Schulte ML, Jones DW, Jarzembowski J, Sorci-Thomas M, Pritchard KA Jr.

J Lipid Res. 2010 Sep;51(9):2560-70. doi: 10.1194/jlr.M004549. Epub 2010 May 24.

17.

Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease.

Patel N, Gonsalves CS, Yang M, Malik P, Kalra VK.

Blood. 2009 Jan 29;113(5):1129-38. doi: 10.1182/blood-2008-07-169821. Epub 2008 Oct 22.

Supplemental Content

Support Center